rs41291566

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_002860.4(ALDH18A1):​c.1029T>C​(p.Ile343Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.029 in 1,614,066 control chromosomes in the GnomAD database, including 861 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 60 hom., cov: 32)
Exomes 𝑓: 0.030 ( 801 hom. )

Consequence

ALDH18A1
NM_002860.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.456

Publications

6 publications found
Variant links:
Genes affected
ALDH18A1 (HGNC:9722): (aldehyde dehydrogenase 18 family member A1) This gene is a member of the aldehyde dehydrogenase family and encodes a bifunctional ATP- and NADPH-dependent mitochondrial enzyme with both gamma-glutamyl kinase and gamma-glutamyl phosphate reductase activities. The encoded protein catalyzes the reduction of glutamate to delta1-pyrroline-5-carboxylate, a critical step in the de novo biosynthesis of proline, ornithine and arginine. Mutations in this gene lead to hyperammonemia, hypoornithinemia, hypocitrullinemia, hypoargininemia and hypoprolinemia and may be associated with neurodegeneration, cataracts and connective tissue diseases. Alternatively spliced transcript variants, encoding different isoforms, have been described for this gene. [provided by RefSeq, Jul 2008]
ALDH18A1 Gene-Disease associations (from GenCC):
  • cutis laxa, autosomal dominant 3
    Inheritance: AD, SD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • ALDH18A1-related de Barsy syndrome
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal recessive complex spastic paraplegia type 9B
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • P5CS deficiency
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • hereditary spastic paraplegia 9A
    Inheritance: AD, SD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • autosomal dominant complex spastic paraplegia type 9B
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal dominant cutis laxa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 10-95627491-A-G is Benign according to our data. Variant chr10-95627491-A-G is described in ClinVar as Benign. ClinVar VariationId is 258823.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.456 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0211 (3215/152248) while in subpopulation NFE AF = 0.0334 (2271/68018). AF 95% confidence interval is 0.0322. There are 60 homozygotes in GnomAd4. There are 1532 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 60 AR,AD,SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALDH18A1NM_002860.4 linkc.1029T>C p.Ile343Ile synonymous_variant Exon 9 of 18 ENST00000371224.7 NP_002851.2 P54886-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALDH18A1ENST00000371224.7 linkc.1029T>C p.Ile343Ile synonymous_variant Exon 9 of 18 1 NM_002860.4 ENSP00000360268.2 P54886-1
ALDH18A1ENST00000371221.3 linkc.1023T>C p.Ile341Ile synonymous_variant Exon 9 of 18 1 ENSP00000360265.3 P54886-2
ALDH18A1ENST00000489386.1 linkn.394T>C non_coding_transcript_exon_variant Exon 3 of 5 3

Frequencies

GnomAD3 genomes
AF:
0.0211
AC:
3215
AN:
152130
Hom.:
60
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00558
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.0110
Gnomad ASJ
AF:
0.0245
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.0384
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0334
Gnomad OTH
AF:
0.0148
GnomAD2 exomes
AF:
0.0228
AC:
5741
AN:
251380
AF XY:
0.0230
show subpopulations
Gnomad AFR exome
AF:
0.00412
Gnomad AMR exome
AF:
0.0100
Gnomad ASJ exome
AF:
0.0243
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0370
Gnomad NFE exome
AF:
0.0355
Gnomad OTH exome
AF:
0.0217
GnomAD4 exome
AF:
0.0298
AC:
43635
AN:
1461818
Hom.:
801
Cov.:
31
AF XY:
0.0292
AC XY:
21220
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.00460
AC:
154
AN:
33480
American (AMR)
AF:
0.0105
AC:
469
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0254
AC:
663
AN:
26132
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39694
South Asian (SAS)
AF:
0.00409
AC:
353
AN:
86258
European-Finnish (FIN)
AF:
0.0389
AC:
2076
AN:
53418
Middle Eastern (MID)
AF:
0.0106
AC:
61
AN:
5768
European-Non Finnish (NFE)
AF:
0.0346
AC:
38465
AN:
1111950
Other (OTH)
AF:
0.0230
AC:
1392
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
2409
4819
7228
9638
12047
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1398
2796
4194
5592
6990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0211
AC:
3215
AN:
152248
Hom.:
60
Cov.:
32
AF XY:
0.0206
AC XY:
1532
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.00556
AC:
231
AN:
41542
American (AMR)
AF:
0.0110
AC:
168
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0245
AC:
85
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4828
European-Finnish (FIN)
AF:
0.0384
AC:
407
AN:
10598
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0334
AC:
2271
AN:
68018
Other (OTH)
AF:
0.0147
AC:
31
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
159
317
476
634
793
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0310
Hom.:
130
Bravo
AF:
0.0186
Asia WGS
AF:
0.00433
AC:
15
AN:
3478
EpiCase
AF:
0.0315
EpiControl
AF:
0.0305

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 07, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

de Barsy syndrome;C1832669:Autosomal dominant spastic paraplegia type 9;C4225268:Cutis laxa, autosomal dominant 3 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia Benign:1
Nov 09, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ALDH18A1-related de Barsy syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.33
DANN
Benign
0.70
PhyloP100
-0.46
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41291566; hg19: chr10-97387248; API